Zhejiang Cheng Yi Pharmaceutical Co (SHSE:603811) EPS (Basic) : ¥0.65 (TTM As of Mar. 2025)

View and export this data going back to 2017. Start your Free Trial

What is Zhejiang Cheng Yi Pharmaceutical Co EPS (Basic)?

Zhejiang Cheng Yi Pharmaceutical Co's basic earnings per share (Basic EPS) for the three months ended in Mar. 2025 was ¥0.14. Its basic earnings per share (Basic EPS) for the trailing twelve months (TTM) ended in Mar. 2025 was ¥0.65.

Zhejiang Cheng Yi Pharmaceutical Co's EPS (Diluted) for the three months ended in Mar. 2025 was ¥0.14. Its EPS (Diluted) for the trailing twelve months (TTM) ended in Mar. 2025 was ¥0.65.

Zhejiang Cheng Yi Pharmaceutical Co's EPS without NRI for the three months ended in Mar. 2025 was ¥0.15. Its EPS without NRIearnings per share without non-recurring items for the trailing twelve months (TTM) ended in Mar. 2025 was 0.53.

During the past 12 months, Zhejiang Cheng Yi Pharmaceutical Co's average EPS without NRIGrowth Rate was 1.20% per year. During the past 3 years, the average EPS without NRI Growth Rate was -6.60% per year. During the past 5 years, the average EPS without NRI Growth Rate was 0.70% per year. During the past 10 years, the average EPS without NRI Growth Rate was 7.60% per year. Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the EPS without NRI Growth Rate using EPS without NRI data.

During the past 13 years, Zhejiang Cheng Yi Pharmaceutical Co's highest 3-Year average EPS without NRI Growth Rate was 29.20% per year. The lowest was -6.60% per year. And the median was 5.20% per year.

Zhejiang Cheng Yi Pharmaceutical Co EPS (Basic) Historical Data

The historical data trend for Zhejiang Cheng Yi Pharmaceutical Co's EPS (Basic) can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Zhejiang Cheng Yi Pharmaceutical Co EPS (Basic) Chart

Zhejiang Cheng Yi Pharmaceutical Co Annual Data

Trend

Dec15

Dec16

Dec17

Dec18

Dec19

Dec20

Dec21

Dec22

Dec23

Dec24

EPS (Basic)

Get a 7-Day Free Trial

0.51

0.52

0.49

0.50

0.61

Zhejiang Cheng Yi Pharmaceutical Co Quarterly Data
	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23	Mar24	Jun24	Sep24	Dec24	Mar25
EPS (Basic)	Get a 7-Day Free Trial															0.10	0.13	0.13	0.25	0.14

Zhejiang Cheng Yi Pharmaceutical Co EPS (Basic) Calculation

EPS (Basic) is a rough measurement of the amount of a company's profit that can be allocated to one share of its stock. Basic earnings per share (EPS) do not factor in the dilutive effects on convertible securities.

Zhejiang Cheng Yi Pharmaceutical Co's Basic EPS for the fiscal year that ended in Dec. 2024 is calculated as

Basic EPS (A: Dec. 2024 )	=	(Net Income	-	Preferred Dividends)	/	Shares Outstanding (Basic Average)
	=	(200.701	-	0)	/	329.018
	=	0.61

Zhejiang Cheng Yi Pharmaceutical Co's Basic EPS for the quarter that ended in Mar. 2025 is calculated as

Basic EPS (Q: Mar. 2025 )	=	(Net Income	-	Preferred Dividends)	/	Shares Outstanding (Basic Average)
	=	(45.793	-	0)	/	327.094
	=	0.14

EPS (Basic) for the trailing twelve months (TTM) ended in Mar. 2025 adds up the quarterly data reported by the company within the most recent 12 months, which was ¥0.65

Zhejiang Cheng Yi Pharmaceutical Co (SHSE:603811) EPS (Basic) Explanation

EPS is the single most important variable used by Wall Street in determining the earnings power of a company. But investors need to be aware that Earnings per Share can be easily manipulated by adjusting depreciation and amortization rate or non-recurring items. That's why GuruFocus lists EPS without NRI, which better reflects the company's underlying performance.

Be Aware

Compared with Earnings per share, a company's cash flow is better indicator of the company's earnings power.

If a company's earnings per share is less than cash flow per share over long term, investors need to be cautious and find out why.

Zhejiang Cheng Yi Pharmaceutical Co EPS (Basic) Related Terms

Thank you for viewing the detailed overview of Zhejiang Cheng Yi Pharmaceutical Co's EPS (Basic) provided by GuruFocus.com. Please click on the following links to see related term pages.

Zhejiang Cheng Yi Pharmaceutical Co Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Zhejiang Cheng Yi Pharmaceutical Co Ltd (SHSE:603811) » Definitions » EPS (Basic)

Traded in Other Exchanges

N/A

Address

Lane 988, Shenhong Road, 7th Floor, No. 9, Building 20, Fuli Yuedu, Minhang District, Shanghai, CHN, 201100

Website

https://www.chengyipharma.com

Zhejiang Cheng Yi Pharmaceutical Co Ltd is a pharmaceutical company that produces capsules, injections, tablets, APIs, and pharmaceutical intermediates in China. Its main products include glucosamine hydrochloride raw materials and preparations, torasemide injection and capsules, Gastrodin raw materials, ribavirin and purine raw materials, and so on.

Executives

Ke Ze Hui	Director
Ren Bing Jun	Director
Yan Yi Yi	Director
Ceng Huan Qun	Director
Li Shi Sheng	Director
Qiu Ke Rong	Director
Lv Sun Zhan	senior management
Zhang Gao Qiao	Supervisors
Zhang Zhi Hong	senior management
Mao Li Ping	senior management
Zhuang Xiao Ping	Director
Lin Xin Chen	senior management
Shen Ai Lan	Director
Zhang Fu Fu	Supervisors

Zhejiang Cheng Yi Pharmaceutical Co Headlines

No Headlines